Day 3 - Wednesday 17th JuneWednesday, 17 June 2026 - CEST Time Zone

• Exploring the evolving role of clinical evidence in the medical device lifecycle, from development to post-market surveillance, and its impact on regulatory compliance.
• Discussing innovative approaches to generating, managing, and leveraging clinical data to meet the increasing demands of global regulatory bodies.
• Looking into future trends, challenges, and opportunities in clinical evidence generation to support device safety, efficacy, and market success.

For more information, please contact Neha Singh at neha.singh@informa.com

• Addressing the difficulty of generating sufficient clinical data for legacy devices to meet MDR/IVDR standards.
• Exploring how manufacturers can implement robust PMS and post-market clinical follow-up plans amidst resource constraints.
• Examining the lack of alignment and consistency MDR/IVDR interpretations - what are the solutions?

• Exploring innovative tools, technologies, and methodologies shaping the future of PMS to ensure compliance and improve patient safety.
• Perspectives on regulatory expectations and best practices for implementing a forward-thinking PMS strategy.

For more information, please contact Neha Singh at neha.singh@informa.com

• Diving into current challenges and opportunities in aligning PMS practices with UK-specific regulatory requirements
• Exploring future trends and strategies for navigating the UK regulatory landscape while ensuring robust PMS compliance